Business
ENDRA Life Sciences Expands Global Technology Protection With New Chinese Patents
Grants further protect ENDRA's TAEUS® platform capabilities in key international market with over 400 million potential NAFLD patientsANN ARBOR, MI /
About this update from Endra Life Sciences Inc.
[{"type":"text","content":"Grants further protect ENDRA's TAEUS® platform capabilities in key international market with over 400 million potential NAFLD patientsANN ARBOR, MI / ACCESSWIRE / July 13, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued Chinese Patents ZL 2016 8 00267289 and ZL 2019 3 04324291 from the Chinese Intellectual Property Office.\"The granting of these patents further expands the protection of our platform technology in the key international market of China, where an estimated 29.2% of the population is affected by Non-Alcoholic Fatty Liver Disease, according to a recent study published in Hepatology,\" said ENDRA's Chief Executive Officer, Francois Michelon. \"We now have six issued patents in China and a total of 31 international IP assets. We plan to continue to expand and broaden this protection for our disruptive diagnostic technology, as commercialization begins this year.\"ENDRA's goal is to develop, patent and commercialize applications for our proprietary TAEUS technology in areas of high unmet clinical need, such as Non-Alcoholic Fatty Liver Disease (NAFLD), which affects over 1 billion people globally and for which there are no practical diagnostic tools.The recently-issued ‘289 Chinese patent claims priority from its parent application in the United States, which issued as US10,028,662 on July 24, 2018. It covers a system and method for imaging biological tissue structures. More particularly, the '289 Chinese patent structurally defines an integrated ultrasound/thermoacoustic system and method, which utilizes a sleeve to physically locate and register the ultrasound and thermoacoustic portions of the invention, relative to each other.The ‘291 Chinese patent recenlty issued in the United States as USD883488S1 on May 5, 2020. The ‘291 patent for \"Thermoacoustic Imaging Probe With Outdents\" protects the appearance of the FLIP probe, including a user-friendly variant of the relevant combination of shapes and surface markings.\"Bringing TAEUS' improved soft-tissue contrast capabilities to point-of-care ultrasound aligns extremely well with China's efforts to provide effective, lower-cost health services to its 1.4 billion citizens by shifting care delivery from small urban hospitals to primary-care community clinics,\" said ENDRA Sci...